[EN] IMIDAZOPYRIDINES AND IMIDAZOPYRIMIDINES AS HIV-I REVERSE TRANSCRIPTASE INHIBITORS<br/>[FR] IMIDAZOPYRIDINES ET IMIDAZOPYRIMIDINES UTILISÉS COMME INHIBITEURS DE LA TRANSCRIPTASE INVERSE DU VIH-1
申请人:CSIR
公开号:WO2010032195A1
公开(公告)日:2010-03-25
The invention provides compounds of formula A or B which are useful in the treatment of a subject infected with HIV.
这项发明提供了公式A或B的化合物,可用于治疗感染HIV的受试者。
[EN] SMALL MOLECULE INHIBITION OF TRANSCRIPTION FACTOR SALL4 AND USES THEREOF<br/>[FR] INHIBITION PAR DES PETITES MOLÉCULES DU FACTEUR DE TRANSCRIPTION SALL4 ET SES UTILISATIONS
申请人:DANA FARBER CANCER INST INC
公开号:WO2019070943A1
公开(公告)日:2019-04-11
Provided herein are compounds that interrupt the function of SALL4. Also described are pharmaceutical compositions and medical uses of these compounds.
IMIDAZOPYRIDINES AND IMIDAZOPYRIMIDINES AS HIV-I REVERSE TRANSCRIPTASE INHIBITORS
申请人:Bode Moira Leanne
公开号:US20110312957A1
公开(公告)日:2011-12-22
The invention provides compounds of formula A or B which are useful in the treatment of a subject infected with HIV.
本发明提供了公式A或B的化合物,其在治疗HIV感染的受试者中具有用处。
Small molecule inhibition of transcription factor SALL4 and uses thereof
申请人:Dana-Farber Cancer Institute, Inc.
公开号:US11530209B2
公开(公告)日:2022-12-20
Provided herein are compounds that interrupt the function of SALL4. Also described are pharmaceutical compositions and medical uses of these compounds.